Former Duke-NUS post-doctoral fellow Dr Debleena Ray has designed the grandest of experiments of her life: Building her own startup // Credit: Courtesy of Debleena Ray
Cancer recurrence is often deadlier than the original disease, especially when it spreads undetected. Yet for survivors, post-treatment monitoring can be a financial, emotional and mental burden—relying on costly, invasive tests with no guarantees.
But what if detecting cancer was as simple as a blood test?
In this episode, Dr Debleena Ray, the founder of the biotech startup 2Strands Biosciences and a former Duke-NUS post-doctoral fellow, shares how she’s bridging research and entrepreneurship to develop cutting-edge, blood-based tests that will revolutionise cancer monitoring.
Listen now: